- Low bankruptcy risk (Altman Z-Score: 22.50)
- Consistently positive technical signals over the last month
- Healthy interest coverage ratio of 12.5x
Weaker technical forecast for Novozymes A/S as stock downgraded to Buy Candidate
(Updated on Jul 31, 2026)
The Novozymes A/S stock price fell by -0.99% on the last day (Friday, 31st Jul 2026) from $65.69 to $65.04. During the last trading day the stock fluctuated 1.81% from a day low at $63.91 to a day high of $65.06. The price has fallen in 6 of the last 10 days but is still up by 0.34% over the past 2 weeks. Volume has increased on the last day by 604 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 thousand shares were bought and sold for approximately $119.09 thousand.
The stock lies in the upper part of a strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $65.80 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 11.91% during the next 3 months and, with a 90% probability hold a price between $67.68 and $73.64 at the end of this 3-month period.
NVZMY Signals & Forecast
There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Thursday, July 30, 2026, and so far it has fallen -0.99%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Novozymes A/S gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The Novozymes A/S stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $63.54 and $62.93. A breakdown below any of these levels will issue sell signals.
Support, Risk & Stop-loss for Novozymes A/S stock
Novozymes A/S finds support from accumulated volume at $61.87 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $1.15 between high and low, or 1.81%. For the last week the stock has had daily average volatility of 1.24%.
Our recommended stop-loss: $62.83 (-3.40%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 1 day ago.)
Trading Expectations (NVZMY) For The Upcoming Trading Day Of Monday 3rd
For the upcoming trading day on Monday, 3rd we expect Novozymes A/S to open at $64.67, and during the day (based on 14 day Average True Range), to move between $64.32 and $65.76, which gives a possible trading interval of +/-$1.44 (+/-2.24%) up or down from last closing price. If Novozymes A/S takes out the full calculated possible swing range there will be an estimated 2.24% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $65.06 (0.03%) than the support at $61.87 (4.87%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Novozymes A/S stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Novozymes A/S stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.
Current score:
2.024
Buy Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on August 3, 2026 - $64.67 ( 0.571%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
NVZMY Performance
Trading levels for NVZMY
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 65.82 | 1.20% |
| R2 | 65.38 | 0.526% |
| R1 | 65.11 | 0.107% |
| Price | 65.04 | |
| S1 | 64.23 | -1.25% |
| S2 | 63.95 | -1.67% |
| S3 | 63.51 | -2.35% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 65.34 | 0.461% |
| R2 | 65.13 | 0.138% |
| R1 | 65.06 | 0.0308% |
| Price | 65.04 | |
| S1 | 61.87 | -4.87% |
| S2 | 59.04 | -9.23% |
| S3 | 58.99 | -9.30% |
NVZMY Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Feb 25, 2026 | Mar 25, 2026 | Apr 10, 2026 | $0.420 | 0.710% |
| 2 | Aug 21, 2025 | Sep 02, 2025 | Sep 11, 2025 | $0.350 | 0.560% |
| 3 | Mar 10, 2025 | Apr 07, 2025 | Apr 23, 2025 | $0.380 | 0.610% |
| 4 | Sep 09, 2024 | Sep 09, 2024 | Sep 18, 2024 | $0.168 | 0.247% |
| 5 | Apr 10, 2024 | May 01, 2024 | May 20, 2024 | $0.185 | 0.292% |
FAQ
Click here for our free guide on how to buy Novozymes A/S Stock.
Buy NVZMY